Handbook of Vitamin C Research

More documents

Recommendations

Info

182Borut Poljsak and John G. Ionescu[139] Singh J, &Carlisle DL, &Pritchard DE, &Patierno SR. (1998) Chromium-inducedgenotoxicity and apoptosis: relationship to chromium carcinogenesis. Oncol Rep5(6):1307-18.[140] Smith, M. A. & Richey Harris, P. L. & Sayer, L. M. & Beckman, J. S. & and Perry, G.(1997). Widespread peroxynitrite-mediated damage in Alzheimer‘s disease. J.Neurosci. 17, 2653–2657.[141] Song, E.J.& Yang, V.C.& Chiang, C.D. & Chao, C.C. (1995). Potentiation of growthinhibition due to vincristine by ascorbic acid in a resistant human non-small cell lungcancer cell line. Eur J Pharmacol, 292, 119–125.[142] Stearns, D.M. & Kennedy, L.J. & Courtney, K.D. & Giangrande, P.H, Phieffer, L.S,Wetterhahn, K.E. (1995). Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 34, 3, 910-9.[143] Stich H.F., & Karim J., Koropatnick J.,& Lo L. (1976). Mutagaenic action of ascorbicacid. Nature, 260, 722–4.[144] Sugiyama M. & Tsuzuki K. & Hidaka T. & Ogura R. & Yamamoto M. (1991).Reduction of chromium(VI) in Chinese hamster V-79 cells. Biol Trace Elem Res 30,1,1-8.[145] Sugiyama M. & Tsuzuki K. & Ogura R. (1991). Effect of ascorbic acid on DNAdamage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromiumin Chinese hamster V-79 cells treated with sodium chromate(VI). J Biol Chem 266,6,3383-3386.[146] Sugiyama M. (1991). Effects of vitamins on chromium(VI) induced damage. EnvironHealth Perspect 92:63-70.[147] Swain J.A, Darley-Usmar V. & Gutteridge J.M.C. (1994). Peroxynitrite releases copperfrom caeruloplasmin: implications for atherosclerosis. FEBS Lett, 342, 49–52.[148] Taper, H.S.& Jamison, J.M.& Gilloteaux, J., et al. (2004). Inhibition of thedevelopment of metastases by dietary vitamin C:K3 combination. Life Sci, 75, 955–967.[149] Telang S., & Clem A.L., & Eaton J.W., & Chesney J. (2007). Depletion of ascorbicacid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia., 9,47–56.[150] Tetef, M.& Margolin, K.& Ahn, C., et al. (1995). Mitomycin C and menadione for thetreatment of lung cancer: a phase II trial. Invest New Drugs,13, 157–162.[151] Tijskens, P. Discovering the Future: Modelling Quality Matters. – WageningenUniversity, 2004[152] The alpha-tocopherol, beta-carotene cancer prevention study. (1994). N. Engl. J. Med. 330,1029.[153] Vaupel P. (2004). The role of hypoxia-induced factors in tumor progression.Oncologist., 9, 10–7.[154] Verrax, J.& Stockis, J.& Tison, A., et al. (2006). Oxidative stress byascorbate/menadione association kills K562 human chronic myelogenous leukaemiacells and inhibits its tumour growth in nude mice. Biochem Pharmacol, 72, 671–680.
Pro-Oxidant vs. Antioxidant Effects of Vitamin C 183[155] Vivekananthan DP, & Penn MS, & Sapp SK,& Hsu A, & Topol EJ. Use of antioxidantvitamins for the prevention of cardiovascular disease: meta-analysis of randomisedtrials. Lancet (2003) 361:2017–23.[156] Vojdani A, & Bazargan M, & Vojdani E, & Wright J. New evidence for antioxidantproperties of vitamin C. Cancer Detect Prev. (2000) 24(6):508-23.[157] Watson, J. D., & Berry, A. DNA: The Secret of Life. Ljubljana: Modrijan, 2007.[158] Winterbourn, C. C. (1981). Hydroxyl radical production in body fluids: roles of metalions, ascorbate and superoxide. Biochem. J. 198, 125–131.[159] Witenberg B. & Kalir H.H. & Raviv Z. & Kletter Y. & Kravtsov V. & Fabian I. (1999).Inhibition of ascorbic acid of apoptosis induced by oxidative stress in HL-60 myeloidleukemia cells. Biochem Pharmacol 57, 823-832.[160] Yaman M, & Atici D, & Bakirdere S, & Akdeniz I. (2005) Comparison of trace metalconcentrations in malign and benign human prostate. J Med Chem 48(2):630-4.[161] Yeh CC, & Hou MF,& Wu SH,& Tsai SM,& Lin SK,& Hou LA,& Ma H, & Tsai LY.(2006) A study of glutathione status in the blood and tissues of patients with breast cancer.Cell Biochem Funct 24(6):555-9.
Page 7 and 8:
ContentsPrefaceChapter IChapter IIC
Page 9 and 10:
PrefaceThe 6-carbon lactone known a
Page 11 and 12:
Prefaceixbalance of antioxidant and
Page 13 and 14:
Prefacexiprovided or is contradicto
Page 15 and 16:
PrefacexiiiChapter IX - Background:
Page 17 and 18:
Prefacexvdetoxification defence sys
Page 19:
Prefacexviiprogressed faster than i
Page 22 and 23:
2Kelsey H. Fisher-Wellman and Richa
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
10Kelsey H. Fisher-Wellman and Rich
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 65 and 66:
In: Handbook of Vitamin C Research
Page 67 and 68:
Human Specific Vitamin C Metabolism
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
mgmgmgHuman Specific Vitamin C Meta
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105:
Page 108 and 109:
88Ana I. Haza, Almudena García and
Page 110 and 111:
90Figure 1.Ana I. Haza, Almudena Ga
Page 112 and 113:
Page 114 and 115:
94Figure 3.Ana I. Haza, Almudena Ga
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
100Ana I. Haza, Almudena García an
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 147 and 148:
In: Handbook of Vitamin C Research:
Page 149 and 150:
Vitamin C: Dietary Requirements, Di
Page 151 and 152: Oxidative DamageVitamin C: Dietary
Page 153 and 154: Vitamin C: Dietary Requirements, Di
Page 173 and 174: In: Handbook of Vitamin C Research:
Page 175 and 176: Pro-Oxidant vs. Antioxidant Effects
Page 183 and 184: Patient. B.H. (38), atopic eczema.V
Page 201: Pro-Oxidant vs. Antioxidant Effects
Page 206 and 207: 186Magdalena Stevanović and Dragan
Page 233 and 234: In: Handbook of Vitamin C Research
Page 235 and 236: Molecular Bases of the Cellular Han
Page 253 and 254:
Molecular Bases of the Cellular Han
Page 255 and 256:
Molecular Bases of the Cellular Han
Page 257 and 258:
Page 259 and 260:
Vitamin C: Daily Requirements, Diet
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279:
Page 282 and 283:
262Alan M. Preston, Luis Vázquez Q
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Percent of Study Group Selecting Di
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 301 and 302:
Page 303 and 304:
The Role of Vitamin C in Human Repr
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317:
Page 320 and 321:
300Mustafa NazıroğluKeywords: Vit
Page 322 and 323:
302Mustafa NazıroğluNO is synthes
Page 324 and 325:
304Mustafa Nazıroğlu‗recycling
Page 326 and 327:
306Mustafa Nazıroğluagents, such
Page 328 and 329:
308Mustafa NazıroğluFuture Direct
Page 330 and 331:
310Mustafa Nazıroğlu[21] Basu, TK
Page 332 and 333:
312Mustafa Nazıroğlu[59] Cengiz M
Page 334 and 335:
314Samar Al Sayegh Petkovšek and B
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
(mgg -1 )320Samar Al Sayegh Petkov
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
330Antonio J. López-Farré, José
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 363 and 364:
Page 365 and 366:
Vitamin C in the Treatment of Endot
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
Vitamin C Intake by Japanese Patien
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Reciprocal Effects of Ascorbate on
Page 391 and 392:
Page 393 and 394:
Page 395:
Page 398 and 399:
378Akihito Ishigamicontrols (12,13)
Page 400 and 401:
380Akihito IshigamiFigure 3. Vitami
Page 402 and 403:
382Akihito IshigamiFuture of the SM
Page 405 and 406:
Page 407 and 408:
The Importance of Food Processing o
Page 409 and 410:
IndexAA , 249abdominal cramps, 243a
Page 411 and 412:
Index 391atherosclerotic plaque, 23
Page 413 and 414:
Index 393catalase, 6, 13, 169, 181,
Page 415 and 416:
Index 395cyclooxygenase-2, 337, 341
Page 417 and 418:
Index 397endometrium, 286, 294endon
Page 419 and 420:
Index 399GCS, 18gel, x, 87, 92, 121
Page 421 and 422:
Index 401hyperglycaemia, 223hypergl
Page 423 and 424:
Index 403kinetics, 71, 120, 124, 14
Page 425 and 426:
Index 405metastases, 182metastasis,
Page 427 and 428:
Index 407nitrate, 14, 88, 179, 234,
Page 429 and 430:
Index 409phosphodiesterase, 344, 35
Page 431 and 432:
Index 411recovery, vii, 1, 5, 7, 8,
Page 433 and 434:
Index 413steady state, 63, 76, 78st
Page 435:
Index 415UV, 156, 191, 201, 204, 22
show all

Handbook of Vitamin C Research

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?